EP1734970
Meðhöndlun á bandvefsmyndun með því að nota FXR-tengla
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
14.3.2005EP published:
31.12.2014EP application number:
05729394.6
EP translation filed:
11.2.2015Grant published:
15.3.2015EPO information:
European Patent Register
Max expiry date:
13.3.2025Expiry date:
13.3.2024
Title:
TREATMENT OF FIBROSIS USING FXR LIGANDS
Timeline
Today
14.3.2005EP application
31.12.2014EP Publication
11.2.2015Translation submitted
15.3.2015Registration published
13.3.2024Expires
Owner
Name:
Intercept Pharmaceuticals, Inc.Address:
421 Hudson Street, Suite 212, 10014, New York, NY, US
Inventor
Name:
FIORUCCI, StefanoAddress:
Perugia, IT
Name:
PELLICCIARI, RobertoAddress:
Perugia, IT
Name:
PRUZANSKI, MarkAddress:
New York, NY, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
552865 PDate:
12.3.2004Country:
US
Classification
Categories:
A61K 31/56
Annual fees
Number
Paid
Expires
Payer
Number: 11
Paid: 11.2.2015
Expires: 13.3.2016
Payer: Árnason Faktor
Number: 12
Paid: 18.2.2016
Expires: 13.3.2017
Payer: Sigurjónsson & Thor ehf.
Number: 13
Paid: 20.2.2017
Expires: 13.3.2018
Payer: Sigurjónsson & Thor ehf.
Number: 14
Paid: 20.2.2018
Expires: 13.3.2019
Payer: Sigurjónsson & Thor ehf.
Number: 15
Paid: 19.2.2019
Expires: 13.3.2020
Payer: Sigurjónsson & Thor ehf.
Number: 16
Paid: 26.2.2020
Expires: 13.3.2021
Payer: Sigurjónsson & Thor ehf.
Number: 17
Paid: 18.2.2021
Expires: 13.3.2022
Payer: Sigurjónsson & Thor ehf.
Number: 18
Paid: 18.2.2022
Expires: 13.3.2023
Payer: Patice ehf.
Number: 19
Paid: 20.2.2023
Expires: 13.3.2024
Payer: Árnason Faktor ehf.